NORMEDI DANMARK ApS: Financial statements 2022
CVR: 35663290
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
NORMEDI DANMARK ApS (CVR 35663290) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,700,571 and a net result of DKK 1,314,529 compared with DKK 474,014 the year before. That is an increase of 71.3% compared with the year before. Equity in the 2022 report amounted to DKK 1,364,788. The solvency ratio was 33.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,700,571
- Profit/Loss
- DKK 1,314,529
- Equity
- DKK 1,364,788
- Total Assets
- DKK 4,083,878
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 2.7M | 1.3M | 1.4M | 1 |
| 2021 | - | 1.6M | 474K | 637K | 1 |
| 2020 | - | 2.3M | 986K | 1.1M | 1 |
| 2019 | - | 1.7M | 624K | 677K | 1 |
| 2018 | - | 738K | 93K | 93K | 1 |
Official annual report
Keep an eye on NORMEDI DANMARK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NORMEDI DANMARK ApS has published its annual report for 2021. Gross profit came to DKK 1,576,322, and the net result was DKK 474,014.
About NORMEDI DANMARK ApS
NORMEDI DANMARK ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2014. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named ApS STAKE NR. 5035. The management consists of Jesper Steffensen. The board consists of Michelangelo Stefani (chair), Jesper Steffensen and Joao Malagueira. The company is owned by Hologic GGO 4 Ltd. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,460,197 and a net result of DKK 386,079 compared with DKK -74,099 the year before. Equity in the 2025 report amounted to DKK 1,852,127.